CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Grant or award Chief Executive Officer acquired 26,668 shares (grant or award)
- 4 Grant or award Pres., R&D, and CMO acquired 20,001 shares (grant or award)
- 4 Open-market sale SVP and General Counsel sold 13,000 shares at an average $282.92 ($3,677,977)
- 4 Open-market sale SVP and General Counsel sold 7,000 shares at an average $274.18 ($1,919,231)
- 4 Open-market sale Chief Commercial Officer sold 30,000 shares at an average $274.14 ($8,224,073)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
- 4 Other disposition 10% owner disposed of 824,172 shares (other)
Page 9 of 29 · 564 filings